Reversible parkinsonism with normal β-CIT-SPECT in patients exposed to sodium valproate
- 27 April 2004
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 62 (8) , 1435-1437
- https://doi.org/10.1212/01.wnl.0000121228.32913.00
Abstract
After reports of reversible parkinsonism and cognitive impairment with sodium valproate (VPA), the authors examined 50 consecutive patients taking VPA and 20 patients taking carbamazepine. Three patients taking VPA exhibited unequivocal parkinsonism with Unified Parkinson Disease Rating Scale scores >30. VPA was withdrawn from two patients with improvement of symptoms. Reduction in VPA dosage in the third patient produced no improvement. β-CIT-SPECT scans were normal, suggesting dopaminergic neuronal loss is not the underlying mechanism.Keywords
This publication has 9 references indexed in Scilit:
- [123I]β‐CIT SPECT distinguishes vascular parkinsonism from Parkinson's diseaseMovement Disorders, 2002
- [123I]β‐CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophyMovement Disorders, 2001
- [123I]?-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degenerationMovement Disorders, 2000
- Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in LondonBMJ, 2000
- Reversible parkinsonism and cognitive impairment with chronic valproate useNeurology, 1996
- Reversible Valproate‐Induced Extrapyramidal DisordersEpilepsia, 1994
- [123I]-2.beta.-carbomethoxy-3.beta.-(4-iodophenyl)tropane: high-affinity SPECT (single photon emission computed tomography) radiotracer of monoamine reuptake sites in brainJournal of Medicinal Chemistry, 1991
- Sensorineural hearing lossNeurology, 1990
- Abnormalities of the electron transport chain in idiopathic parkinson's diseaseAnnals of Neurology, 1989